StockData
GENELUX Corp logo

GENELUX Corp (GNLX) stock

GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$1.86−0.03 (-1.84%)

Close on Nov 13, 2026Market cap $84.38MP/E –Yield –

Genelux operating margin

Operating margin is operating income as a percentage of revenue.

Genelux's operating margin for the twelve months ending Dec 31, 2024 was -396200.0%. For fiscal 2025 it was -415175.0%, against -396200.0% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-415175.0%−18975.0
FY2024Dec 31, 2024-396200.0%−381985.3
FY2023Dec 31, 2023-14214.7%−14187.5
FY2022Dec 31, 2022-27.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2024Mar 31, 2024-101437.5%–
Q1 FY2023Mar 31, 2023-3801.2%–
Q4 FY2022Dec 31, 2022-4550.0%–
Q3 FY2022Sep 30, 202257.7%–

More Genelux figures

See a number that looks wrong?